IRBM S.p.A
|
Year Established:
2010 |
|
|
Website:
irbm.com |
|
|
Headquarters:
Pomezia, , IT |
|
|
Company Type:
Mid-Sized Business (10-100M TTM Revenue) |
|
|
Completed Requests:
9 |
|
|
Open Requests:
3 |
|
Certifications:
|
With decades of success delivering clinical candidates from nascent research projects, IRBM is an independent, fully integrated contract research organization performing core research across the entire drug discovery pipeline. Our deep expertise in the discovery and optimization of small molecule, antibody and peptide therapeutics make IRBM the provider of choice for anyone looking to augment their process with seasoned drug hunters.
We Make Drugs.
IRBM’s team has a notable track record, developing 4 marketed therapeutics:
ISENTRESS®, the first-in-class HIV integrase inhibitor
Grazoprevir, part of the HCV ZEPATIER® combination therapy
ZOLINZA®, a HDAC inhibitor for cutaneous T cell lymphoma
ZEJULA®, a PARP inhibitor for the treatment of ovarian cancer
| Site | Badges | |
|---|---|---|
| IRBM S.p.A Via Pontina Km 30,600 Pomezia, , 00071 Italy | ||
| IRBM S.p.A Via Pontina Km 30,600 Pomezia, , 00071 Italy | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.